Andere talen Madrigal Pharmaceuticals, Inc.

Aandelen

MDGL

US5588681057

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
212 ^USD	-4,60%		-10,38%	-8,36%

11/04	Madrigal Pharmaceuticals Insider verkocht aandelen ter waarde van $658.258, volgens een recente SEC filing	MT
11/04	Madrigal Pharmaceuticals Insider verkocht aandelen ter waarde van $6.467.491, volgens een recente SEC filing	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	16/04
Madrigal Pharmaceuticals Insider Sold Shares Worth $658,258, According to a Recent SEC Filing	11/04
Madrigal Pharmaceuticals Insider Sold Shares Worth $6,467,491, According to a Recent SEC Filing	11/04
Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis	10/04
Madrigal Pharmaceuticals Says Rezdiffra Available in US	09/04
Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis	09/04
Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis	09/04
Madrigal Pharmaceuticals Insider Sold Shares Worth $8,214,998, According to a Recent SEC Filing	04/04
Madrigal Pharmaceuticals Insider Sold Shares Worth $8,218,630, According to a Recent SEC Filing	04/04
Madrigal Pharmaceuticals Insider Sold Shares Worth $2,832,335, According to a Recent SEC Filing	04/04
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	03/04
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	19/03
EE.UU. - Valores a seguir en Wall Street (actualizado)	19/03
Madrigal Pharmaceuticals : Super Micro Computer, Madrigal, Tencent... les valeurs à suivre aujourd'hui à Wall Street -	19/03
Madrigal Pharmaceuticals : lève 600 millions de dollars pour le lancement de son Rezdiffra	19/03
Madrigal Pharmaceuticals Prices $600 Million Public Offering	19/03
Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering	19/03
Madrigal Pharmaceuticals Starts $500 Million Public Offering	18/03
Madrigal plans $500 million fund raising to prepare for NASH drug launch	18/03
Madrigal commences $500 million public offering of common stock	18/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Madrigal Pharmaceuticals, Inc.

Aandelen

MDGL

US5588681057

Andere talen

Filters